Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis. - Wikidata - wikimedia - TriplyDB

Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis.

Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis.

http://www.wikidata.org/entity/Q36649655

about

Size-uniform 200 nm particles: fabrication and application to magnetofection A chemical view of oligonucleotides for exon skipping and related drug applications RGDechi-hCit: αvβ3 selective pro-apoptotic peptide as potential carrier for drug delivery into melanoma metastatic cells Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor.Intracellular traffic of oligodeoxynucleotides in and out of the nucleus: effect of exportins and DNA structure Characterization and performance of nucleic acid nanoparticles combined with protamine and gold.Multicellular tumor spheroids as a model for assessing delivery of oligonucleotides in three dimensions Tumor cell-targeted delivery of nanoconjugated oligonucleotides in composite spheroids Antisense oligodeoxynucleotide inhibition as an alternative and convenient method for gene function analysis in pollen tubes Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes Multifunctional drug nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapy High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides.Nucleic Acid Bioconjugates in Cancer Detection and Therapy.In vivo delivery of cell-permeable antisense hypoxia-inducible factor 1α oligonucleotide to adipose tissue reduces adiposity in obese mice.Retro-1 Analogues Differentially Affect Oligonucleotide Delivery and Toxin Trafficking.The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides.U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides Sub-cellular temporal and spatial distribution of electrotransferred LNA/DNA oligomer ENDOCYTOSIS PATHWAYS FOR NUCLEIC ACID THERAPEUTICS.Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.The delivery of therapeutic oligonucleotides Gastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imaging Therapeutic potential of splice-switching oligonucleotides.Biological barriers to therapy with antisense and siRNA oligonucleotides.Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.Applications for site-directed molecular imaging agents coupled with drug delivery potential.Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.Integrin targeted delivery of gene therapeutics Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.Oligonucleotide conjugates for therapeutic applications.New Modalities for Challenging Targets in Drug Discovery.Two-Dimensional Fluorescence Difference Spectroscopy to Characterize Nanoparticles and their Interactions Bioconjugates for targeted delivery of therapeutic oligonucleotides.Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide.The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking.Cellular uptake and intracellular trafficking of oligonucleotides Azide-alkyne cycloaddition for universal post-synthetic modifications of nucleic acids and effective synthesis of bioactive nucleic acid conjugates.Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotides

P2860

Q24652501-0B2BB6B5-78DC-4BED-A4C5-A041473BE4F4 Q26863684-B630C598-07D0-4177-9DA6-482191A5D123 Q28543148-47EEA815-E80D-4569-A699-26F08BACB339 Q30434397-6518F28A-4FF8-482F-A655-39E19B0F57C1 Q30497657-02C0A1C0-5B44-4248-B2D0-47F193D72E6A Q33499568-0D7E4F19-0A26-48E1-97D6-2514C91C69E2 Q33637214-8017E1C2-E2D4-41AE-9F8A-2CDE8B13E4F2 Q34606502-2140150C-7C8C-4266-9A55-8CBBDA1256F0 Q34634669-CB70A487-9851-41B5-BB0C-9A4FA571CBB8 Q35097999-09DF0128-88AE-445F-ACBF-BB378D3743B2 Q35108257-D659EFDA-A605-4D5B-BB2D-0B432769A512 Q35131115-A83693A6-9C95-40D1-B904-45944CB5230F Q35867875-27C4EC01-9404-4198-AFD1-39938740ABFA Q36044388-EC527202-4236-4C40-AE57-FC085E015BE7 Q36173801-39A9F45E-BBA1-478C-B5E3-51FE74473A50 Q36740806-106758CC-065E-4404-9949-B71C38010AE7 Q36757152-CE5AC4D8-7193-410F-BDD0-B79192384A2E Q37015817-04992911-0E52-4051-BCA9-B86D4C049DA0 Q37029450-E89F0766-CE6E-4639-BC42-6D7A6C6B9CC1 Q37094403-DD0DA7C2-3AB8-411D-A061-1F1307EED2F7 Q37193000-BE80B02D-2A8E-461C-852B-63B9E3F646CD Q37210936-116D0C85-31B4-495F-82C5-7B5DD901841D Q37236396-D84B8EB9-83B8-4390-9B92-FE5B9D3C7596 Q37363171-73D91AA8-BB26-42B2-A279-7E91E491D2B5 Q37378340-08B096EA-C4AC-42BC-8652-EC3CDB37F958 Q37383038-637A53A3-145C-478E-90E3-3757BFCE8E06 Q37529871-F9ECC1A7-87DB-4D09-A2C3-FE9078067B3D Q37656119-76BAB28D-2010-4A25-B040-56852FE9E931 Q37850458-ABB409CE-C846-4100-BEEB-F3E67A648E95 Q37872613-302BA54E-2237-4207-9C41-56BD1516A330 Q37944929-265B1183-D296-4692-9361-BA2459F4E898 Q38123854-5C6F70F8-8E83-4681-969F-EECF1E967853 Q38289100-A78F7634-6096-4887-AC04-6A3F3962C407 Q38290917-CCF584E3-0AE9-4679-8F86-44B7212BD504 Q38301011-CD79224D-93F8-4760-8B81-610361A9B82A Q38314361-7637AB20-7132-4E40-8167-EABDE50686D9 Q38347631-F0F63229-38BE-4A9A-A386-CF09C0B53BAE Q38424377-F30413A4-2C82-48EA-9CE8-190DF9767EDC Q38976926-BF05686E-5498-4762-8499-BC234C07ECCA Q39041906-5627F9CB-97D9-42A6-9BAF-A43661FBEF2A

P2860

Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis.

http://www.wikidata.org/entity/Q36649655

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Intracellular delivery of an a ...... receptor-mediated endocytosis.

@ast

Intracellular delivery of an a ...... receptor-mediated endocytosis.

@en

type

label

Intracellular delivery of an a ...... receptor-mediated endocytosis.

@ast

Intracellular delivery of an a ...... receptor-mediated endocytosis.

@en

prefLabel

Intracellular delivery of an a ...... receptor-mediated endocytosis.

@ast

Intracellular delivery of an a ...... receptor-mediated endocytosis.

@en

P1433

Q36649655-E1E05B25-02A6-4477-9A78-43FDF78EF545

P1476

Q36649655-E158EAF6-226A-4AA0-A75E-3AD76E488E93

P2093

Q36649655-004973AF-F537-4F24-86F1-14E7F9666348

Q36649655-0D38AC9D-9024-4683-8437-D2B1B8DDCDFA

Q36649655-168ED31B-3DB9-4360-B392-C437C23CC415

Q36649655-6F7F1C1C-8913-4761-902D-1981D89DA938

Q36649655-7CC23B95-9A22-40FC-A7D1-6B3BDEC192AB

Q36649655-8179598D-2A55-45BA-9E10-530C0FF0EB64

Q36649655-C1C4EFC0-4716-4DC4-9246-FFF2D4DA65F5

Q36649655-F10667BF-F5A1-4558-B796-1CFAEBB789EF

P2860

Q36649655-02E914E0-A26C-4C60-9E22-33A2B3340071

Q36649655-04CD40BF-DE97-4A66-9B83-72A23AFCAA37

Q36649655-04D8D306-DB88-454E-857E-6A35CA03017B

Q36649655-04F2F7E1-259F-4ABA-8698-6DA94FCC9CD8

Q36649655-06E14758-5DCB-4935-9465-64D1108BFD91

Q36649655-0A86EC39-AD61-44AD-B3A5-31B27827F194

Q36649655-0F509CB7-7261-45F2-95A8-258D724D1FBB

Q36649655-154A0C99-601A-4DEC-9384-7DD4E9402110

Q36649655-1586049A-5AE3-4366-9DD9-A7C7789D3069

Q36649655-180FE7B8-BCFE-42A8-8CDE-458DB26C4CAE

P304

Q36649655-0DB4ABB1-41D2-4BEA-A4EF-46169A811CC8

P31

Q36649655-81341F69-4905-496A-8A24-9C0A04969557

P356

Q36649655-8CB10F29-93E6-4C2B-9A57-1319AEF34D1E

P407

Q36649655-B364EFED-D394-4F4A-B8AF-1F8A01268A4B

P433

Q36649655-B7594BA3-46A8-4E88-866D-2C2836925BA8

P478

Q36649655-09EB5A84-5447-4A4C-95D1-F8E05DA4D83E

P577

Q36649655-09376AF8-A5DE-493D-8864-DC51F414301B

P5875

Q36649655-CD19C3C1-A62C-4954-9403-471854D460F7

P698

Q36649655-35063647-EE6C-4AD3-B7B5-957C158B6F9E

P932

Q36649655-0C1F6AA5-3ED7-4CD5-86D3-A849B17CDF8A

P356

P1433

Nucleic Acids Research

P1476

Intracellular delivery of an a ...... receptor-mediated endocytosis.

@en

P2093

Hyunmin Kang

http://www.w3.org/2001/XMLSchema#string

Joann Trejo

http://www.w3.org/2001/XMLSchema#string

Md Rowshon Alam

http://www.w3.org/2001/XMLSchema#string

Michael Fisher

http://www.w3.org/2001/XMLSchema#string

Rudy L Juliano

http://www.w3.org/2001/XMLSchema#string

Vidula Dixit

http://www.w3.org/2001/XMLSchema#string

Xiaoyuan Chen

http://www.w3.org/2001/XMLSchema#string

Zi-Bo Li

http://www.w3.org/2001/XMLSchema#string

P2860

alpha v beta3 and alpha5beta1 integrin recycling pathways dictate downstream Rho kinase signaling to regulate persistent cell migration.

An essential role for SNX1 in lysosomal sorting of protease-activated receptor-1: evidence for retromer-, Hrs-, and Tsg101-independent functions of sorting nexins

Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides

Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells

Rab proteins as membrane organizers

Strategies for silencing human disease using RNA interference

Alternative pre-mRNA splicing: the logic of combinatorial control

Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control.

Synthesis and hybridization analysis of a small library of peptide-oligonucleotide conjugates

Nanogels for oligonucleotide delivery to the brain.

P304

2764-2776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/GKN115

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5485923

http://www.w3.org/2001/XMLSchema#string

P698

18367474

http://www.w3.org/2001/XMLSchema#string

P932

2377441

http://www.w3.org/2001/XMLSchema#string